The AME of mutant B2M status on metastasis location is 0.6494 (~65%), meaning that on average a B2M-mutant tumor has a ~65% higher probability of having a peritoneal/peritoneal and lymphatic metastasis (p = 0.0006). Here, B2M is linked to neoplasm.